Onderneming Mirna Therapeutics Inc Nasdaq
Aandelen
US60470J1034
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Synthetic Biology Therapeutics
100,0
%
| 1 | 100,0 % | 3 | 100,0 % | +185,68% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 3 | 100,0 % | +185,68% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mary Dooley
DFI | Director of Finance/CFO | 43 | 01-06-18 |
Brendan St Amant
LAW | General Counsel | - | 01-07-21 |
Molly Harper
PRN | Corporate Officer/Principal | 48 | 27-09-21 |
Caroline Kurtz
PRN | Corporate Officer/Principal | - | 01-10-16 |
Thomas J. Adam
HRO | Human Resources Officer | - | 28-08-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Shea
BRD | Director/Board Member | 72 | 28-08-17 |
Peter Barrett
CHM | Chairman | 71 | 28-08-17 |
Director/Board Member | 64 | 01-10-12 | |
Director/Board Member | 59 | 08-12-20 | |
Nick Leschly
BRD | Director/Board Member | 51 | 28-08-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 11 986 803 | 9 884 522 ( 82,46 %) | 279 792 ( 2,334 %) | 82,46 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,85% | 57,87 mld. | |
+41,42% | 40,25 mld. | |
-5,25% | 39,94 mld. | |
-5,16% | 28,54 mld. | |
+12,79% | 26,4 mld. | |
-20,18% | 19,33 mld. | |
+30,88% | 12,4 mld. | |
+0,61% | 12,23 mld. | |
+25,06% | 12,2 mld. |